Cargando…
Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), a high mortality malignancy, has become a worldwide public health concern. Acquired resistance to the multikinase inhibitor sorafenib challenges its clinical efficacy and the survival benefits it provides to patients with advanced HCC. This study aimed to identify cri...
Autores principales: | Jiang, Xili, Zhang, Wei, Li, Lifeng, Xie, Shucai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560649/ https://www.ncbi.nlm.nih.gov/pubmed/34737677 http://dx.doi.org/10.3389/pore.2021.1609985 |
Ejemplares similares
-
Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population
por: Xie, Yuning, et al.
Publicado: (2022) -
Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma
por: Jiang, Wenru, et al.
Publicado: (2023) -
Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2022) -
Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021) -
Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)